renal cell carcinoma

Open Access
Molecular Characteristics of Everolimus-resistant Renal Cell Carcinoma Cells Generated by Continuous Exposure to Everolimus
YUKO NAKAYAMA, DAICHI ENOMOTO, KAZUHIRO YAMAMOTO and KOHJI TAKARA

Anticancer Research October 2023, 43 (10) 4349-4357; DOI: https://doi.org/10.21873/anticanres.16630
You have access
T1a Renal Cell Carcinoma With Metastasis: Japanese Society of Renal Cancer Retrospective Multi-institute Results
TAIGO KATO, CONG WANG, NAOYA MASUMORI, TOSHINARI YAMASAKI, HIROAKI MATSUMOTO, MASAYA BABA, KEIICHI ITO, TAKAHIRO KIMURA, HIROSHI KITAMURA, MASAYUKI TAKAHASHI, FUMIYA HONGO, KATSUYOSHI HASINE, MASATOSHI ETO, JUN-ICHIRO IKEDA, NORIO NONOMURA and NOBUO SHINOHARA

Anticancer Research September 2023, 43 (9) 4061-4065; DOI: https://doi.org/10.21873/anticanres.16595
You have access
Pre-operative Plasma Fibrinogen Level as a Potential Predictor of Pathological T3 Upstaging in Clinically Localized Renal Cell Carcinoma
SHO SEKITO, SHIORI TANAKA, GOSHI KITANO, MANABU KATO, YUJI OGURA and TAKAHIRO KOJIMA

Anticancer Research September 2023, 43 (9) 4229-4235; DOI: https://doi.org/10.21873/anticanres.16615
Open Access
Long-term Outcome With Prolonged Use of Interferon-alpha Administered Intermittently for Metastatic Renal Cell Carcinoma: A Phase II Study
MINNA KANKURI-TAMMILEHTO, LAURA PERASTO, SEPPO PYRHONEN and EEVA SALMINEN

Anticancer Research June 2023, 43 (6) 2645-2657; DOI: https://doi.org/10.21873/anticanres.16431
You have access
Robotic Retroperitoneal Versus Transperitoneal Partial Nephrectomy: Outcomes and Learning Curve
NICOLAS FISCHER, TOBIAS KOWALKE, MANUELA A. HOFFMANN and DANIEL PORRES

Anticancer Research June 2023, 43 (6) 2741-2747; DOI: https://doi.org/10.21873/anticanres.16441
Open Access
Liver Metastases of Unknown Primary Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors: A Case Report and Literature Review
DAVIDE BIMBATTI, NICOLÒ CAVASIN, FRANCESCA GALUPPINI, ALESSANDRO RAGO, GAETANO RAMONDO, ELEONORA LAI, MICHELE DIONESE, ELISA ERBETTA, UMBERTO BASSO and MARCO MARUZZO

Anticancer Research May 2023, 43 (5) 2359-2365; DOI: https://doi.org/10.21873/anticanres.16401
You have access
Feasibility of Computed Tomography-guided Percutaneous Renal Cryoablation Under Local Anesthesia: A Single Center Experience in Taiwan
YEN-TING LIN, SIU-WAN HUNG, MING-CHENG LIU, KUN-YUAN CHIU, JYH-WEN CHAI and JIN-CHING LIN

Anticancer Research April 2023, 43 (4) 1699-1708; DOI: https://doi.org/10.21873/anticanres.16322
Open Access
The Potential Impact of New Drug and Therapeutic Modalities on Drug Resistance to Renal Cell Carcinoma
PEDRO CAETANO PINTO

Anticancer Research March 2023, 43 (3) 983-991; DOI: https://doi.org/10.21873/anticanres.16242
You have access
Prognostic Value of Serum Soluble PD-L1 in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab
NAOTO WAKITA, NOBUYUKI HINATA, YUKARI BANDO, TAKUTO HARA, TOMOAKI TERAKAWA, JUNYA FURUKAWA, YUZO NAKANO and MASATO FUJISAWA

Anticancer Research February 2023, 43 (2) 841-847; DOI: https://doi.org/10.21873/anticanres.16226
You have access
Improved Survival of Real-world Japanese Patients With Advanced Renal Cell Carcinoma Treated With Immuno-oncology Combination Therapy
KOSUKE UEDA, SHIGETAKA SUEKANE, HIROFUMI KUROSE, NAOKI ITO, NAOYUKI OGASAWARA, TASUKU HIROSHIGE, KATSUAKI CHIKUI, KAZUHISA EJIMA, KEIICHIRO UEMURA, MAKOTO NAKIRI, KIYOAKI NISHIHARA, MITSUNORI MATSUO and TSUKASA IGAWA

Anticancer Research September 2022, 42 (9) 4573-4580; DOI: https://doi.org/10.21873/anticanres.15960

Main menu

User menu

Search

renal cell carcinoma

Pages